Results for 'EMA'
Monty Pal
Rewriting the Rules of Cellular Therapy
City of Hope, Monty Pal, Stephen Forman, hematologic malignancy, cellular immunotherapy, bone marrow, CAR-T cell therapy
Dr. Stephen Forman shares the past, present, and future of cellular therapy and how City of Hope is building care systems to reach more patients.
Jul 21st • 47 mins listen
MSL Talk: Tom Caravela, Amy Misnik
The Importance of Networking for MSLs with Amy Misnik
MSL industry, Hematology Oncology, MSL networking, Medical Science Liaison, pharmaceutical career
Today I have Amy Misnik on the podcast. She is the Director, Medical Science Liaisons, Hematology Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson. Today she will be sharing about her role and you will be hearing our discussion about the importance of networking in the …
Mar 26th • 35 mins listen
MSL Talk: Tom Caravela, Rachel Kennedy, Lashondra Taylor, Nirav Shah
Diversity in Medical Affairs and the Power of Networking
networking in medical affairs, DEMA mission, career advancement tips, medical affairs professionals, diversity in medical affairs
In this episode, Tom Caravela welcomes guests Rachel Kennedy, Lashondra Taylor, and Nirav Shah to discuss the formation and mission of DEMA. They explore the transformative power of networking, sharing Rachel's inspiration behind DEMA and how to engage with the organization. The conversation in…
Jan 5th • 36 mins listen
The Oncology Nursing Podcast
CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation
“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…
May 24th • 40 mins listen
Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Monty Pal
How a Bold Yes Became a Scientific Breakthrough
City of Hope, Monty Pal, Linda Malkas, AOH1996, Ana Olivia Healy
Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.
Jun 9th • 47 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Rebecca Previs, Suzanne Garner, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Monty Pal
How Team Science Fuels Cancer Breakthroughs: A Conversation with Dr. Marcel van den Brink
KOL, City of Hope, Marcel van den Brink, Monty Pal, T cell, thymus, immune recovery, microbiome, transplant outcomes
In the season 4 premiere of On the Edge of Breakthrough: Voices of Cancer Research, Monty Pal, M.D., F.A.S.C.O., welcomes Marcel van den Brink, M.D., Ph.D., President of City of Hope Los Angeles and City of Hope National Medical Center, Chief Physician Executive and the Deana and Steve Campbell Phys…
Feb 10th • 57 mins listen
Michael Pietrack
ASPIRING MSL INSIGHTS - What you need to know about phone etiquette
👉 Did you know that phone etiquette costs some aspiring MSLs their dream job? With so much stacked against you in trying to get your first MSL job, don’t allow your phone skills to be what stumbles you. In this short video we will discuss two pro tips that will ensure the call with the HM s…
Sep 26th • 3 mins listen
Michael Pietrack
Season 1, Episode 13: Leadership Through Vulnerability with Gwen Binder
In today's episode our host Michael Pietrack sits down with Gwendolyn Binder, President of Science and Technologies at Cabaletta Bio, shares her insights on leadership. She discusses how she became an accidental leader and the importance of focusing on advancing the ball for patients rather tha…
Jun 10th • 28 mins listen
Michael Pietrack
Season 2, Episode 18: Turning the Page with Chadi Nabhan
Join Michael Pietrack on the Pharmaverse Podcast as he sits down with Dr. Chadi Nabhan, MD – CMO and Head of Strategy at RyghtAI, hematologist, oncologist, author, and podcast host – to explore the future of clinical trials, AI innovation, and leadership in healthcare. In this episode, …
Sep 15th • 23 mins listen
Asco Daily News Podcast
Enhancing Treatment Efficacy in Multiple Myeloma at ASCO24
Drs. John Sweetenham and Marc Braunstein discuss practice-changing studies in hematologic malignancies that were featured at the 2024 ASCO Annual Meeting, including the ASC4FIRST trial in chronic myeloid leukemia and IMROZ and CARTITUDE-4 in multiple myeloma.
Jun 24th • 23 mins listen
The Oncology Nursing Podcast
Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon
ONS members Meghan Coleman, DNP, CRNP, and Alison McDaniel, BSN, RN, OCN®, join Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss their Evidence-Based Quality Understanding in Pathology (EQUIP) project to solve unequal access to germline and s…
Dec 24th • 46 mins listen
The Oncology Nursing Podcast
Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care
ONS members Kristin Daly, MSN, ANP-BC, AOCNP®, medical oncology nurse practitioner at the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, MO, and Jessica Pforr, RN, AOCNP®, nurse practitioner at Mon Medical Center in Morgantown, WV, join Stephanie Jardine,…
Mar 29th • 38 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen